Login / Signup

Mycobacterium ChelonaeDeveloping Multidrug Resistance.

Vinod Kumar MannelliManoj Ponadka RaiDivyesh Reddy NemakayalaNaga Preethi Kadiri
Published in: BMJ case reports (2018)
Mycobacterium chelonae is a rapidly growing mycobacterium which is known to respond well to standard antibiotic treatment regimen. There are no specific guidelines for treatment. Antibiotics are chosen based on the bacterial sensitivity. Here we present a 47-year-old man with hip replacement who developed bright red papular generalised skin lesions and bilateral hip abscess. On workup, it was confirmed that M. chelonae was the causative organism. He was given 8 weeks of antibiotics; however, there was worsening of the hip abscess on interval imaging. The progression was most likely due to M. chelonae developing antibiotic resistance. Physicians should be aware of the rising resistance of this organism, and guide antibiotic therapy based on bacterial sensitivity to yield better outcomes.
Keyphrases
  • mycobacterium tuberculosis
  • primary care
  • high resolution
  • stem cells
  • skeletal muscle
  • combination therapy
  • bone marrow
  • clinical practice
  • mass spectrometry
  • soft tissue
  • photodynamic therapy
  • rare case
  • wound healing